{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:39:11Z","timestamp":1788424751971,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Neuromuscular blockade (NMB) is a critical part of many surgical procedures. Data on practice patterns of NMB agents (NMBAs) and NMB reversal in recent years in the US ambulatory surgical care setting are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This retrospective analysis of US adult outpatients was conducted using the Premier Healthcare Database. We describe anesthesia practice trends in NMB management and assess the association of patient, procedural, and site characteristics with NMB reversal approach using multivariable logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Approximately 5.2 million outpatient surgical encounters involving NMB and 4.6 million involving rocuronium or vecuronium between January 2014 and June 2019 were included. Following the introduction of sugammadex to US clinical practice (~2016), there was an increased use of rocuronium or vecuronium and a decrease in succinylcholine alone. Before 2016, NMB was pharmacologically reversed with neostigmine in approximately two-thirds of outpatient encounters. Over time, active reversal increased; by 2019, 42.3% and 36.0% of encounters were reversed by neostigmine and sugammadex, respectively, with 21.7% undergoing spontaneous recovery. Choice of NMBA (rocuronium or vecuronium alone), time since 2016, obesity, peripheral vascular disease, and procedures on the digestive, ocular, and female genital systems (vs musculoskeletal procedures) were independently and positively associated with pharmacologic reversal (versus spontaneous reversal). Conversely, advanced age; Western geography; and cardiovascular, endocrine, hemic\/lymphatic, respiratory, and ear, nose, and throat procedures were independently and negatively associated with pharmacologic reversal of NMB.<\/jats:p>\n                    <jats:p>\n                      Among pharmacologic reversals, time since 2016 was positively and independently associated with sugammadex compared with neostigmine (odds ratios [ORs], ranged from 1.8 in 2017 to 3.2,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .0001 in 2019). Those administered rocuronium or vecuronium without succinylcholine, with increased age and history of certain comorbidities, and those undergoing ocular or respiratory procedures (compared with musculoskeletal) were positively associated with reversal with sugammadex and endocrine procedure negatively and independently associated with reversal with sugammadex. There was variability in the association of several factors with NMB reversal choices by geographic region, particularly in patients\u2019 race, ethnicity, and size of affiliated hospital.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Overall, active pharmacological reversal of NMB increased in US adult outpatients following the introduction of sugammadex, although there remains significant practice variability. The multifactorial relationship between patient-, procedural-, and environmental-level characteristics and NMB management is rapidly evolving. Additional research on how these anesthesia practice patterns may be impacted by the shift to the ambulatory care setting and how they may impact patient outcomes and health disparities is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000005657","type":"journal-article","created":{"date-parts":[[2021,11,16]],"date-time":"2021-11-16T16:01:44Z","timestamp":1637078504000},"page":"1437-1450","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Neuromuscular Blockade and Reversal Practice Variability in the Outpatient Setting: Insights From US Utilization Patterns"],"prefix":"10.1213","volume":"133","author":[{"given":"Lori D.","family":"Bash","sequence":"first","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Kenilworth, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wynona","family":"Black","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Turzhitsky","sequence":"additional","affiliation":[{"name":"Center for Observational and Real-World Evidence (CORE), Merck & Co, Inc, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,11,15]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1136\/postgradmedj-2016-134311","article-title":"The role of technology in minimally invasive surgery: state of the art, recent developments and future directions.","volume":"93","author":"Tonutti","year":"2017","journal-title":"Postgrad Med J"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/ACO.0b013e3283593100","article-title":"History of anesthesia for ambulatory surgery.","volume":"25","author":"Urman","year":"2012","journal-title":"Curr Opin Anaesthesiol"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1377\/hlthaff.2013.1281","article-title":"Procedures take less time at ambulatory surgery centers, keeping costs down and ability to meet demand up.","volume":"33","author":"Munnich","year":"2014","journal-title":"Health Aff (Millwood)"},{"key":"R6-20250502","first-page":"6177","article-title":"Clinical and cost implications of inpatient versus outpatient orthopedic surgeries: a systematic review of the published literature.","volume":"7","author":"Crawford","year":"2015","journal-title":"Orthop Rev (Pavia)"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2044.2003.03150.x","article-title":"A comparison of the effect of two anaesthetic techniques on surgical conditions during gynaecological laparoscopy.","volume":"58","author":"Williams","year":"2003","journal-title":"Anaesthesia"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/aas.12419","article-title":"Neuromuscular blockade for optimising surgical conditions during abdominal and gynaecological surgery: a systematic review.","volume":"59","author":"Madsen","year":"2014","journal-title":"Acta Anaesthesiol Scand"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"e1654","DOI":"10.1097\/MJT.0000000000000206","article-title":"Safety and efficacy of rocuronium with sugammadex reversal versus succinylcholine in outpatient surgery\u2014a multicenter, randomized, safety assessor-blinded trial.","volume":"23","author":"Soto","year":"2016","journal-title":"Am J Ther"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"12","DOI":"10.37765\/ajac.2020.88679","article-title":"Medicare accountable care organizations reduce spending on surgery.","volume":"8","author":"Modi","year":"2020","journal-title":"Am J Accountable Care"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s40140-014-0082-5","article-title":"Preoperative optimization of patients undergoing ambulatory surgery.","volume":"4","author":"Fong","year":"2014","journal-title":"Curr Anesthesiol Rep"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jclinane.2017.06.006","article-title":"Sugammadex efficacy for reversal of rocuronium- and vecuronium-induced neuromuscular blockade: a pooled analysis of 26 studies.","volume":"41","author":"Herring","year":"2017","journal-title":"J Clin Anesth"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/EJA.0b013e32833d56b7","article-title":"Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial.","volume":"27","author":"Blobner","year":"2010","journal-title":"Eur J Anaesthesiol"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/ALN.0b013e31818a3fee","article-title":"Reversal of profound rocuronium-induced blockade with sugammadex: a randomized comparison with neostigmine.","volume":"109","author":"Jones","year":"2008","journal-title":"Anesthesiology"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2253-10-15","article-title":"Reversal of profound vecuronium-induced neuromuscular block under sevoflurane anesthesia: sugammadex versus neostigmine.","volume":"10","author":"Lemmens","year":"2010","journal-title":"BMC Anesthesiol"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1213\/ane.0b013e3181ac53c3","article-title":"Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.","volume":"110","author":"Khuenl-Brady","year":"2010","journal-title":"Anesth Analg"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/anae.14160","article-title":"The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.","volume":"73","author":"Hristovska","year":"2018","journal-title":"Anaesthesia"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1213\/ANE.0000000000005080","article-title":"Utilization patterns of perioperative neuromuscular blockade reversal in the United States: a retrospective observational study from the Multicenter Perioperative Outcomes Group.","volume":"131","author":"Dubovoy","year":"2020","journal-title":"Anesth Analg"},{"key":"R29-20250502","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"R31-20250502","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00000542-199909000-00022","article-title":"A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers.","volume":"91","author":"Apfel","year":"1999","journal-title":"Anesthesiology"},{"key":"R32-20250502","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1213\/ANE.0000000000004833","article-title":"Fourth consensus guidelines for the management of postoperative nausea and vomiting.","volume":"131","author":"Gan","year":"2020","journal-title":"Anesth Analg"},{"key":"R35-20250502","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/ACO.0000000000000255","article-title":"Providing value in ambulatory anesthesia.","volume":"28","author":"Fosnot","year":"2015","journal-title":"Curr Opin Anaesthesiol"},{"key":"R36-20250502","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1213\/01.ane.0000195543.61123.1f","article-title":"Postoperative residual paralysis in outpatients versus inpatients.","volume":"102","author":"Cammu","year":"2006","journal-title":"Anesth Analg"},{"key":"R37-20250502","first-page":"167","article-title":"Trends and costs of anterior cervical discectomy and fusion: a comparison of inpatient and outpatient procedures.","volume":"38","author":"Martin","year":"2018","journal-title":"Iowa Orthop J"},{"key":"R38-20250502","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/ALN.0000000000000005","article-title":"Patient selection for day case-eligible surgery: identifying those at high risk for major complications.","volume":"119","author":"Mathis","year":"2013","journal-title":"Anesthesiology"},{"key":"R39-20250502","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","article-title":"Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis.","volume":"132","author":"Kheterpal","year":"2020","journal-title":"Anesthesiology"},{"key":"R40-20250502","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1213\/ANE.0000000000002670","article-title":"Consensus statement on perioperative use of neuromuscular monitoring.","volume":"127","author":"Naguib","year":"2018","journal-title":"Anesth Analg"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:29:14Z","timestamp":1786112954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000005657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000005657","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,15]]}}}